Find a staffer, agency or former employer

For example: Rebeckah Adcock, Agriculture, White House, Heritage Foundation, Trump Organization

Scott gottlieb

Scott Gottlieb

Health and Human Services (joined: May 9, 2017)

Commissioner, Food and Drug Administration | Financial Disclosure »

Bio, via Department of Health and Human Services:

Dr. Scott Gottlieb was sworn in as the 23rd Commissioner of Food and Drugs on May 11, 2017. Dr. Gottlieb is a physician, medical policy expert, and public health advocate who previously served as the FDA's Deputy Commissioner for Medical and Scientific Affairs and before that, as a senior advisor to the FDA Commissioner. He also worked on implementation of the Medicare drug benefit as a senior advisor to the Administrator of the Centers for Medicare and Medicaid Services, where he supported policy work on quality improvement and the agency’s coverage process, particularly as it related to new medical technologies. In 2013 Dr. Gottlieb was appointed by the Senate to serve on the Federal Health Information Technology Policy Committee, which advises the Department of Health and Human Services on healthcare information technology. Dr. Gottlieb was previously a Resident Fellow at the American Enterprise Institute, and a Clinical Assistant Professor at the New York University School of Medicine in Manhattan, where he also practiced medicine as a hospitalist physician. He completed a residency in internal medicine at the Mount Sinai Medical Center in New York, New York and is a graduate of the Mount Sinai School of Medicine and of Wesleyan University, in Middletown, Connecticut, where he studied Economics.

Former Positions Outside Government

Former Compensation Sources

See more financial disclosure details ⬇

Employment Assets

Description Value Income
American Enterprise Institute (Think Tank) $210,916
CREF Global Equities AEI Retirement Plan $100,001 - $250,000 None (or less than $201)
New Enterprise Associates (Venture Capital) $280,000
BDO Center for Healthcare Excellence & Innovation $180,000
GlaxoSmithKline plc (Drug Company) $87,153
Daichii Sankyo U.S. (Drug Company) $52,207
Tolero Pharmaceuticals (Biotech Company) $37,500
Tolero Pharmaceuticals Stock Options None (or less than $1,001) $193,111
Forbes Magazine LLC (Publishing Company) $2,864
Eagle Small Cap Growth Fund (MUTF:HRSCX) $100,001 - $250,000 $2,501 - $5,000
PIMCO Total Return Fund (MUTF:PTTRX) $15,001 - $50,000 $1,001 - $2,500
DFA U.S. Small Cap Value Fund (MUTF:DFSVX) $1,001 - $15,000 $201 - $1,000
Emmaus Life Sciences (Biotech Company ) $4,500
American Pathology Partners stock options (value not readily ascertainable): 220,000 options to purchase shares @ $.04/share expires 08/13/2022. Vested None (or less than $201)
Gradalis and Strike Bio (Biotech Company) $65,000
Gradalis and Strike Bio Stock Options (value not readily ascertainable) Strike Bio 25,000 Options to purchase shares at $1.93/Share expires 05/15/24; Gradalis 25,000 Options to purchase shares at 3.16/Share expires 03/21/26 and 25,000 Options to purchase shares at $3.57/Share expires 05/15/24. Vested None (or less than $201)
Glytec Stock Options (value not readily ascertainable) 15,000 Options to purchase shares at $1.35/Share expires 02/13/24 and 5,578 Options to purchase shares at $7.60/Share expires 02/13/25 and 6,101 Options to purchase shares at $5.71/Share expires 06/01/26. Vested None (or less than $201)
FPA Capital Fund (MUTF:FPPTX) $15,001 - $50,000 $1,001 - $2,500
Marsico Focus Fund (MUTF:MFOCX) $15,001 - $50,000 $201 - $1,000
Scott Gottlieb, MD Consulting (Independent Consulting Business) $81,767
Doubleline Total Return Bond Fund (MUTF: DLTNX) $1,001 - $15,000 $201 - $1,000
T Rowe Price Global Stock Fund (MUTF:PRGSX) $50,001 - $100,000 $1,001 - $2,500
Wintergreen Fund (MUTF:WGRNX) $1,001 - $15,000 $201 - $1,000
First Eagle Global Fund Class A (MUTF:SGENX) $1,001 - $15,000 $201 - $1,000
iShares Select Dividend ETF (NYSE:DVY) $1,001 - $15,000 $201 - $1,000
Weitz Partners III Opportunity Fund (MUTF:WPOPX) $15,001 - $50,000 $1,001 - $2,500
Wasatch International Opportunities Fund (MUTF:WAIOX) $15,001 - $50,000 $1,001 - $2,500
Wasatch Small Cap Growth (MUTF:WAAEX) $15,001 - $50,000 $1,001 - $2,500
CombiMatrix Options (value not readily ascertainable) Surrendered in their Entirety Upon Resignation from the Board of Directors 12/19/16 None (or less than $1,001) None (or less than $201)
Columbia European Equity Fund (MUTF:AXEAX) $1,001 - $15,000 $201 - $1,000
Akre Focus Fund Retail (MUTF:AKREX) $15,001 - $50,000 $201 - $1,000
Franklin Mutual European Fund (MUTF:TEURX) $1,001 - $15,000 $201 - $1,000
T. Rowe Price European Stock Fund (MUTF:PRESX) $1,001 - $15,000 $201 - $1,000
Oakmark Fund (MUTF:OAKMX) $15,001 - $50,000 $1,001 - $2,500
Longleaf Partners Fund (MUTF:LLPFX) $100,001 - $250,000 $2,501 - $5,000
FPA Crescent Fund (MUTF:FPACX) $15,001 - $50,000 $1,001 - $2,500
Fidelity Japan Smaller Companies (MUTF:FJSCX) $15,001 - $50,000 $201 - $1,000
Powershares DB Commodity Index ETF (NYSE:DBC) $1,001 - $15,000 $201 - $1,000
iShares Select Dividend ETF (NYSE:DVY) $1,001 - $15,000 $201 - $1,000
iShares MSCI Emerging Markets ETF (NYSE:EEM) $15,001 - $50,000 $1,001 - $2,500
iShares MSCI Eurozone ETF (NYSE:EZU) $15,001 - $50,000 $1,001 - $2,500
Innovating Healthcare LLC $49,000
Van Eck Vectors Natural Resources ETF (NYSE:HAP) $1,001 - $15,000 $201 - $1,000
Lillis Energy (NASDAQ:LLEX) $50,001 - $100,000 None (or less than $201)
Lyrical U.S. Value Equity Fund (MUTF:LYRBX) $15,001 - $50,000 $1,001 - $2,500
Van Eck Vectors Agribusiness ETF (NYSE:MOO) $1,001 - $15,000 $201 - $1,000
Pimco Commodity Real Return (MUTF:PCRDX) $1,001 - $15,000 $201 - $1,000
iShares TIPS Bond ETF (NYSE:TIP) $100,001 - $250,000 $2,501 - $5,000
SPDR DoubleLine Total Return Tact ETF (NYSE:TOTL) $250,001 - $500,000 $2,501 - $5,000
Vanguard Index Reit ETF (NYSE:VNQ) $15,001 - $50,000 $201 - $1,000
Vanguard Index Growth ETF (NYSE:VUG) $1,001 - $15,000 $201 - $1,000
Weitz Partners III Opportunity Fund (MUTF:WPOPX) $15,001 - $50,000 $1,001 - $2,500
Sector SPDR Energy ETF (NYSE:XLE) $50,001 - $100,000 $1,001 - $2,500
Sector SPDR Utilities ETF (NYSE:XLU) $1,001 - $15,000 $201 - $1,000
Tivorsan Pharmaceuticals Warrants (value not readily ascertainable) 256,506 Warrants to purchase shares at $0.01/Share expires 11/25/20. Vested None (or less than $201)
Combimatrix Corporation $30,662
Collective Health Options (value not readily ascertainable) 200,000 options to purchase shares at $.024/Share expires 08/27/24. Vested None (or less than $201)
T.R. Winston & Company (Merchant Bank) $1,849,784
Social Reality (NASDAQ:SRAX) Warrants (value not readily ascertainable) 16,000 warrants to purchase shares at $7.50/Share expires 10/30/17 and 7,000 warrants to purchase shares at $5.00/Share expires 08/22/18. Vested None (or less than $201)
Angion Pharmaceuticals Warrants (value not readily ascertainable) 85.62 warrants to purchase shares at $1,247.94/Share expires 09/06/21. Vested None (or less than $201)
Synthesis Energy Systems, Inc. (NASDAQ:SYMX) Warrants (value not readily ascertainable) 50,000 warrants to purchase shares at $2.25/Share expires 09/28/17. Vested None (or less than $201)
Lillis Energy, Inc (NASDAQ:LLEX) Warrants (value not readily ascertainable) 5,000 warrants to purchase shares at $25.00/Share expires 08/01/17. Vested None (or less than $201)
Emmaus Life Sciences, Inc Warrants (value not readily ascertainable) 54,000 warrants to purchase shares at $3.50/Share expires 09/11/18. Vested None (or less than $201)
Pharma-Bio Serv Inc (NASDAQ:PBSV) Warrants (value not readily ascertainable) 275,000 warrants to purchase shares at $1.80/Share expires 12/01/19. Vested None (or less than $201)
Prosetta Biosciences Warrants (value not readily ascertainable) 40,000 warrants to purchase shares at $4.50/Share expires 02/11/21. Vested None (or less than $201)
Neuralstem, Inc (NASDAQ:CUR) Warrants (value not readily ascertainable) 22,308 warrants to purchase shares at $39.00/Share expires 08/13/18. Vested None (or less than $201)
Inspyr Therapeutics, Inc (NASDAQ:NSPX) Warrants (value not readily ascertainable) 667 warrants to purchase shares at $52.50/Share expires 08/20/18 and 889 warrants to purchase shares at $45.00/Share expires 08/20/18. Vested None (or less than $201)
MedAvante Stock Options (value not readily ascertainable) 50,000 Options to purchase shares at $3.25/Share. Vested None (or less than $201)
Combimatrix (NASDAQ:CBMX) 4,804 Shares None (or less than $1,001) None (or less than $201)
Cell Biotherapy, Inc Options (value not readily ascertainable) 101,961 options to purchase shares at $1.00/Share expires 7/21/26. Vested None (or less than $201)
Tolero Pharmaceuticals Contingent Value Rights (CVR fully vested. Value not readily ascertainable) 97,946 Shares None (or less than $201)
Goldman Sachs & Co. - 01/05/16 (Booked through WorldWide Speakers Bureau) $7,500
Merck & Co, Inc - 01/25/16 and 03/29/16 (Booked through WorldWide Speakers Group) $10,000
InVentiv Health Inc. - 01/12/16 (Booked through WorldWide Speakers Group) $11,250
Lincoln Healthcare HomeCare 100 - 02/8/16 (Booked through WorldWide Speakers Group) $11,250
Generic Pharmaceutical Association - 02/24/16 (Booked through WorldWide Speakers Group) $11,250
Biogen Inc. - 04/12/16 (Booked through WorldWide Speakers Group) $11,250
Thermo Fisher Scientific - 06/15/16 (Booked through WorldWide Speakers Group) $7,000
Institute for International Research - 09/21/16 (Booked through WorldWide Speakers Group) $7,500
Healthcare Distribution Management Association - 09/27/16 (Booked through WorldWide Speakers Group) $11,250
University of Tennessee College of Medicine - 09/28/16 (Booked through WorldWide Speakers Group) $7,500
Lincoln Healthcare Hospital 100 - 10/17/16 (Booked through WorldWide Speakers Group) $10,000
Health Insights - 10/27/16 (Booked through WorldWide Speakers Group) $11,250
Stifel, Nicolaus & Company - 10/28/16 (Booked through WorldWide Speakers Group) $11,250
Mallinckrodt Pharmaceuticals (Delivered in London) - 11/16/16 (Booked through WorldWide Speakers Group) $22,500
Jeffries & Co. London - 11/16/16 (Booked through WorldWide Speakers Group) $11,250
Johnson & Johnson - 01/17/17 (Booked through WorldWide Speakers Group) $11,250
Association for Accessible Medicines - 02/15/17 (Booked through WorldWide Speakers Group) $11,250
CVS Health - 03/29/16 (Booked through WorldWide Speakers Group) $4,000
National Comprehensive Cancer Network - 04/01/16 $3,000
American Academy of Orthopedic Surgeons - 05/06/16 $3,000
HealthCare Royalty Partners - 06/07/16 $5,000
Mikart Pharma - 09/28/16 $5,000
Association of Independent Physicians - 11/05/16 $5,000
GTCR - 02/25/16 (Booked through WorldWide Speakers Group) $5,000
YourEncore $43,200
iShares U.S. Energy ETF (NYSE:IYE) $15,001 - $50,000 $201 - $1,000
VanEck Vector Gold ETF (NYSE:GDX) $15,001 - $50,000 $1,001 - $2,500
Op Ed Article. The Four Legs of the New Health-Care System, The Wall Street Journal - 11/30/16 $200
Op Ed Article. Clinton’s Stealthy Single-Payer Gambit, The Wall Street Journal - 09/14/16 $600
Op Ed Article. How Obama’s FDA Keeps Generic Drugs off the Market, The Wall Street Journal - 08/19/16 $600
Op Ed Article. Applying to Zika the Forgotten Lessons of Ebola, The Wall Street Journal - 02/09/16 $600
Op Ed Article. Warning: Medicare May Be Bad for Your Heart, The Wall Street Journal - 04/11/16 $600
NEA 14 Limited Partnership (passive investor) None (or less than $1,001) None (or less than $201)
NEA 15 Limited Partnership (passive investor) None (or less than $1,001) None (or less than $201)
MedAvante Preferred Stock - 95 Series A Preferred Shares and .26% ownership of the MedAvante Co-Invest Fund, for which the only underlying asset is MedAvante Preferred Stock $15,001 - $50,000 None (or less than $201)
U.S. Renal Care Preferred Stock - 82.946 Class A Preferred Units $250,001 - $500,000 None (or less than $201)
Radiology Partners Common Stock - 50,000 common shares $100,001 - $250,000 None (or less than $201)
Bright Health Preferred Stock - 9,796 common and series A preferred shares $15,001 - $50,000 None (or less than $201)
Collective Health Preferred Stock - 66,540 series B preferred shares $15,001 - $50,000 None (or less than $201)
Golden State Medical Preferred Stock - 75,000 preferred shares at $1.00/share $50,001 - $100,000 None (or less than $201)
Angion Pharmaceuticals Preferred Stock - 20 preferred shares $15,001 - $50,000 None (or less than $201)
Emmaus Life Sciences, Inc Common Stock - 5,988 common shares at $3.50/share $15,001 - $50,000 None (or less than $201)
Cell BioTherapy Inc Common Stock - 25,000 common shares $15,001 - $50,000 None (or less than $201)
Kure Common Stock - 97,000 common shares $1,001 - $15,000 None (or less than $201)
Chanticleer Holdings (NASDAQ:HOTR) Warrants - 8,000 warrants to purchase shares at $1.25/share expires 10/27/19 None (or less than $1,001) None (or less than $201)
Emmaus Life Sciences, Inc Warrants - 5,988 warrants to purchase shares at $3.50/share expires 09/11/18 None (or less than $1,001) None (or less than $201)
Glytec Restricted Stock - 17,738 restricted shares $15,001 - $50,000 None (or less than $201)
MedImpact Speech (Booked through WorldWide Speakers Group) - 03/09/17 $11,250
Pharmacy Benefit Managers Institute Speech (Booked through WorldWide Speakers Group) - 03/06/17 $11,250
Receivable: GlaxoSmithKline Fourth Quarter 2016 Payment $1,001 - $15,000 None (or less than $201)
Receivable: GlaxoSmithKline First Quarter 2017 Payment $1,001 - $15,000 None (or less than $201)
Tolero Pharmaceuticals Common Stock None (or less than $1,001) $100,001 - $1,000,000

Other Income/Assets

Description Value Income
Social Reality Stock (NASDAQ:SRAX) $50,001 - $100,000 None (or less than $201)
SPDR DoubleLine Total Return Tactical ETF (NYSE:TOTL) $250,001 - $500,000 $2,501 - $5,000
iShares TIPS Bond ETF (NYSE:TIP) $50,001 - $100,000 $1,001 - $2,500
Vanguard REIT Index Fund ETF (NYSE:VNQ) $1,001 - $15,000 $201 - $1,000
U.S. Bank Account (cash) $50,001 - $100,000 None (or less than $201)
U.S. Bank Account (cash) $15,001 - $50,000 None (or less than $201)
U.S. Bank Account (cash) $15,001 - $50,000 None (or less than $201)
New Hampshire Moderate Growth Fidelity 529 (Owned across three different dependent child accounts) $100,001 - $250,000 None (or less than $201)
U.S. Bank Account (cash) $50,001 - $100,000 None (or less than $201)
Coinbase Account (Bitcoin) $15,001 - $50,000 $2,501 - $5,000

Employment Agreements and Arrangements

Employer or Party City, State Status and Terms Date
American Enterprise Institute Washington, DC, District of Columbia I will continue to participate in this defined contribution plan. The plan sponsor will not make further contributions after my separation. June 16, 2002
New York University School of Medicine New York, New York I will relinquish this affiliation Jan. 16, 2011
Tolero Pharmaceuticals Lehi, Utah Options have been fully exercised and sold. I will divest myself of the remaining contingent value right. March 16, 2015
American Pathology Partners (AP2) Nashville, Tennessee I will divest my vested stock options. All shares vested March 16, 2012
Gradalis and Strike Bio Dallas, Texas I will divest my vested stock options. All shares vested June 16, 2014
Glytec Greenville, South Carolina I will divest my vested stock options. I will divest my restricted shares. All shares vested March 16, 2013
MedAvante Princeton, New Jersey I will divest my vested stock options. All shares vested Sept. 16, 2007
CombiMatrix Irvine, California Unvested restricted stock units (RSUs) and all options were forfeited in their entirety upon my prior resignation from Board of Directors Jan. 16, 2009
Scott Gottlieb, MD (The sole proprietorship will be placed into inactive status during my government service and any outstanding fees will be fixed before I enter government.) Westport, Connecticut I will continue to participate in this defined contribution plan. The plan sponsor will not make further contributions after my separation. Sept. 16, 2009
American Enterprise Institute HSA Washington, District of Columbia The HSA account will be rolled into a new HSA under the FEHBP Nov. 15, 2007
Cell BioTherapy, Inc Los Angeles, California I will divest my vested stock options. All shares vested May 16, 2016
Collective Health San Francisco, California I will divest my vested stock options. All shares vested July 16, 2014
Social Reality (Related to professional services delivered by T.R. Winston) Los Angeles, California I will divest my stock warrants Aug. 16, 2013
Angion Pharmaceuticals (Related to professional services delivered by T.R. Winston) Uniondale, New York I will divest my stock warrants Sept. 16, 2016
Tivorsan Pharmaceuticals (Related to professional services delivered by T.R. Winston) Providence, Rhode Island I will divest my stock warrants Jan. 16, 2016
Synthesis Energy Systems, Inc (Related to professional services delivered by T.R. Winston) Houston, Texas I will divest my stock warrants Sept. 16, 2014
Lillis Energy, Inc (Related to professional services delivered by T.R. Winston) Houston, Texas I will divest my stock warrants Jan. 16, 2014
Emmaus Life Sciences (Related to professional services delivered by T.R. Winston) Los Angeles, California I will divest my stock warrants Sept. 16, 2013
Pharma-Bio Serv Inc (Related to professional services delivered by T.R. Winston) Plymouth Meeting, Pennsylvania I will divest my stock warrants April 16, 2015
Prosetta Biosciences (Related to professional services delivered by T.R. Winston) San Francisco, California I will divest my stock warrants Feb. 15, 2016
Neuralstem, Inc (Related to professional services delivered by T.R. Winston) Germantown, Maryland I will divest my stock warrants Aug. 16, 2013
Inspyr Therapeutics, Inc (Related to professional services delivered by T.R. Winston) San Antonio, Texas I will divest my stock warrants Aug. 16, 2013
MedAvante Hamilton, New Jersey There could be one-time cash payment to compensate for past, uncompensated consulting and board service from 2007-2017 in the event of a financial sale of the company, in the amount of $400,000. Sept. 16, 2007
GlaxoSmithKline Philadelphia, Pennsylvania Pursuant to the company's compensation arrangement for my service on the Product Investment Board (PIB) I will receive a payment within two months for my service in the fourth quarter of 2016, from October 1, 2016 to December 31, 2016. It will be in the amount of $15,000, reflecting my contracted retainer of $5,000 per month. I will also receive a $15,000 payment for my service during the first quarter of 2017, which will be invoiced on the last day of March 2017 and be payable within 60 days, pursuant to the Company's 60-day payment terms. Jan. 16, 2010

Liabilities

Creditor Name Creditor Type Amount Rate Year Incurred
Navient Sallie Mae (Loan first acquired in 1995 while a medical student and re-financed in 2002 into a 20-year fixed loan) Student Loan $15,001 - $50,000 3.50% 2002
Navient MedLoans (Loan first acquired in 1995 while a medical student and re-financed in 2002 into a 20-year variable loan) Student Loan $15,001 - $50,000 3.00% 2002
TD Bank Exercised Line of Credit $100,001 - $250,000 3.25% 2016
Caliber Home Loan Mortgage on Personal Residence $250,001 - $500,000 3.50% 2013
Bank of America Mortgage on Personal Residence $500,001 - $1,000,000 4.35% 2010

Spouse's Employment Assets

Description Value Income Type Income Amount
Doubleline Total Return Bond Fund (MUTF:DLTNX) $15,001 - $50,000 $201 - $1,000
Fidelity Dividend Growth (MUTF:FDGFX) $1,001 - $15,000 None (or less than $201)
Fidelity Diversified International (MUTF:FDIVX) $1,001 - $15,000 None (or less than $201)
Fidelity Equity Income (MUTF:FEQIX) $1,001 - $15,000 None (or less than $201)
Fidelity Mid Cap Stock (MUTF:FMCSX) (Total consulting fee includes reimbursed travel expenses) $1,001 - $15,000 None (or less than $201)
Janus Overseas Fund (MUTF:JAOSX) (This total reported fee includes reimbursed travel expenses. It will be reported on the CMS "Open Payments" website in a category marked "promotional speaking/other.") $1,001 - $15,000 $201 - $1,000
Oakmark International Fund (MUTF:OAKIX) $1,001 - $15,000 $201 - $1,000
Fairholme Fund (MUTF:FAIRX) (Options fully exercised and sold) $1,001 - $15,000 $201 - $1,000
Wintergreen Fund (MUTF:WGRNX) $1,001 - $15,000 $201 - $1,000

Do you know something about Scott Gottlieb? Send us an email at [email protected] or send a Signal message to 347-244-2134.

See more staffers at Health and Human Services »

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page